Výsledky vyhledávání - Thomas Powles
- Zobrazuji výsledky 1 - 20 z 173
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events Autor Viktor Grünwald, Martin H. Voss, Brian I. Rini, Thomas Powles, Laurence Albigès, Rachel H. Giles, Eric Jonasch
Vydáno 2020Revisão -
12
Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection Autor Thomas Powles, David Robinson, Justin Stebbing, Jonathan Shamash, Mark Nelson, Brian Gazzard, Sundhiya Mandelia, Henrik Møller, Mark Bower
Vydáno 2008Artigo -
13
-
14
-
15
-
16
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma Autor Thomas Powles, Laurence Albigès, Axel Bex, Viktor Grünwald, Camillo Porta, Giuseppe Procopio, Manuela Schmidinger, Cristina Suárez, Guillermo de Velasco
Vydáno 2021Artigo -
17
-
18
Hypothalamo-Pituitary Abnormalities in Adult Patients with Langerhans Cell Histiocytosis: Clinical, Endocrinological, and Radiological Features and Response to Treatment Autor Gregory Kaltsas, Thomas Powles, Jane Evanson, P N Plowman, J. E. Drinkwater, P Jenkins, JP Monson, G. M. Besser, Ashley Grossman
Vydáno 2000Artigo -
19
Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patients Autor Thomas Powles, Sergio Bracarda, Chen Mei, Elliot Norry, Natalie Compton, Mark Heise, Thomas E. Hutson, Philipp Harter, Christopher L. Carpenter, Lini Pandite, Neil Kaplowitz
Vydáno 2015Revisão -
20
Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma Autor Jennifer L. Beaumont, John M. Salsman, Jose Diaz, Keith C. Deen, Lauren McCann, Thomas Powles, Michelle D. Hackshaw, Robert J. Motzer, David Cella
Vydáno 2016Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Cancer
Oncology
Immunotherapy
Renal cell carcinoma
Bladder cancer
Urology
Sunitinib
Chemotherapy
Nivolumab
Clinical trial
Biology
Clinical endpoint
Pembrolizumab
Surgery
Urothelial carcinoma
Confidence interval
Metastatic Urothelial Carcinoma
Randomized controlled trial
Hazard ratio
Cancer research
Pathology
Atezolizumab
Adverse effect
Gastroenterology
Immunology
Kidney cancer
Environmental health
Population